Form 483

Klarity Medical Products LLC Form 483, 2026-05-20

FDA issued a Form 483 to Klarity Medical Products LLC on 2026-05-20 with 8 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health8 observations

Klarity Medical Products LLC · Heath, United States · Issued May 20, 2026

Overview

  • 8 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 May 2026
ISO 13485:2016 Clause 7.3.9

Records of design and development changes and their reviews not maintained

Cited by Javonica F Penn

20 May 2026
ISO 13485:2016 Clause 7.3.9

Records of design and development changes and their reviews not maintained

Cited by Javonica F Penn

20 May 2026
ISO 13485:2016 Clause 7.4.1

Records of supplier (re)evaluation, selection, and monitoring not maintained

Cited by Javonica F Penn

20 May 2026
ISO 13485:2016 Clause 7.4.1

Records of supplier (re)evaluation, selection, and monitoring not maintained

Cited by Javonica F Penn

20 May 2026
ISO 13485:2016 Clause 7.5.6

Procedures for validation of processes not documented

Cited by Javonica F Penn

Inspected site

KMKlarity Medical Products LLCHeath, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
ISO 13485:2016 Clause 7.3.9Cited across public-safe Form 483 observations2x
ISO 13485:2016 Clause 7.4.1Cited across public-safe Form 483 observations2x
ISO 13485:2016 Clause 7.5.6Cited across public-safe Form 483 observations2x
ISO 13485:2016 Clause 8.3.4Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 8 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere